Leandro Vetcher
Founder at Clade Therapeutics, Inc.
Profile
Leandro Vetcher was the founder of Keclon SA (2011) and Green Pacific Biologicals, Inc. (2008), where he held the title of Chief Executive Officer & Director.
He is also the founder of Clade Therapeutics, Inc. Mr. Vetcher's former job was as a Researcher at Kosan Biosciences, Inc. Mr. Vetcher's education includes a graduate degree from The Trustees of Columbia University in The City of New York, an MBA degree from Massachusetts Institute of Technology, and an undergraduate degree from National University of Rosario.
Leandro Vetcher active positions
Companies | Position | Start |
---|---|---|
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Founder | - |
Former positions of Leandro Vetcher
Companies | Position | End |
---|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Keclon SA
Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | Founder | - |
Green Pacific Biologicals, Inc.
Green Pacific Biologicals, Inc. Chemicals: SpecialtyProcess Industries Green Pacific Biologicals, Inc. develops algae biofuel technologies and produces algae biofuel. The firm also produces algae biofuel. The company was founded by Ian Burbulis, Carlos Gustavo Pesce, Wallace Marshall, Richard Yu and Leandro Vetcher on July 14, 2008 and is headquartered in San Francisco, CA. | Founder | - |
Training of Leandro Vetcher
The Trustees of Columbia University in The City of New York | Graduate Degree |
Massachusetts Institute of Technology | Masters Business Admin |
National University of Rosario | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Green Pacific Biologicals, Inc.
Green Pacific Biologicals, Inc. Chemicals: SpecialtyProcess Industries Green Pacific Biologicals, Inc. develops algae biofuel technologies and produces algae biofuel. The firm also produces algae biofuel. The company was founded by Ian Burbulis, Carlos Gustavo Pesce, Wallace Marshall, Richard Yu and Leandro Vetcher on July 14, 2008 and is headquartered in San Francisco, CA. | Process Industries |
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Health Technology |
Keclon SA
Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | Health Technology |
- Stock Market
- Insiders
- Leandro Vetcher